Intraperitoneal Paclitaxel and Carboplatin in the Treatment of Women With Carcinoma of Mullerian Origin
Status:
Completed
Trial end date:
2006-05-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the safety and tolerability of giving both
paclitaxel and carboplatin in the abdominal cavity by looking at what effects (good and bad)
this route of administration has on patients with ovarian cancer. Standard chemotherapy drugs
are administered intravenously but a number of trials have shown that injecting drugs into
the abdominal cavity, or intraperitoneally, have shown promising results.
Phase:
Phase 2
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborators:
Brigham and Women's Hospital Dana-Farber Cancer Institute